Home  About us  Contact
 

Therapy

Distribution by Scientific Domains
Medical Sciences86%
Life Sciences6%
Psychology2%
11 Other Domains6%
Distribution within Medical Sciences
Dermatology8%
Gastroenterology & Hepatology6%
Cardiovascular Disease4%
Hematology3%
Allergy & Clinical Immunology2%
103 Other Subdomains52%

Kinds of Therapy

  • ablation therapy
  • ablative therapy
  • ace inhibitor therapy
  • acid photodynamic therapy
  • acid suppressive therapy
  • acid therapy
  • acid-suppressive therapy
  • active antiretroviral therapy
  • active therapy
  • acute stroke therapy
  • acyclovir therapy
  • ad therapy
  • adalimumab therapy
  • add-on therapy
  • additional therapy
  • adequate therapy
  • adjunct therapy
  • adjunctive therapy
  • adjuvant hormonal therapy
  • adjuvant radiation therapy
  • adjuvant systemic therapy
  • adjuvant therapy
  • adoptive t-cell therapy
  • agent therapy
  • aggressive immunosuppressive therapy
  • aggressive therapy
  • agonist therapy
  • aid therapy
  • airway pressure therapy
  • albendazole therapy
  • alloantigen gene therapy
  • alternative therapy
  • amiodarone therapy
  • analgesic therapy
  • analogue therapy
  • androgen ablation therapy
  • androgen deprivation therapy
  • androgen therapy
  • androgen-deprivation therapy
  • angiogenic therapy
  • antagonist therapy
  • anthracycline therapy
  • anti-angiogenic therapy
  • anti-asthma therapy
  • anti-cancer therapy
  • anti-hbv therapy
  • anti-inflammatory therapy
  • anti-microbial therapy
  • anti-platelet therapy
  • anti-rejection therapy
  • anti-retroviral therapy
  • anti-tnf therapy
  • anti-tumour necrosis factor therapy
  • anti-vegf therapy
  • anti-viral therapy
  • antiangiogenic therapy
  • antiarrhythmic drug therapy
  • antiarrhythmic therapy
  • antibacterial therapy
  • antibiotic therapy
  • antibody therapy
  • anticancer therapy
  • anticoagulant therapy
  • anticoagulation therapy
  • anticonvulsant therapy
  • antidepressant therapy
  • antidiabetic therapy
  • antiepileptic therapy
  • antifungal therapy
  • antihypertensive drug therapy
  • antihypertensive therapy
  • antiinflammatory therapy
  • antimicrobial therapy
  • antineoplastic therapy
  • antioxidant therapy
  • antiplatelet therapy
  • antipsychotic drug therapy
  • antipsychotic therapy
  • antireflux therapy
  • antiresorptive therapy
  • antiretroviral therapy
  • antithrombotic therapy
  • antituberculosi therapy
  • antiviral combination therapy
  • antiviral therapy
  • aphasia therapy
  • appropriate antibiotic therapy
  • appropriate antifungal therapy
  • appropriate icd therapy
  • appropriate therapy
  • art therapy
  • arv therapy
  • aspirin therapy
  • asthma therapy
  • atorvastatin therapy
  • augmentation therapy
  • available therapy
  • bcg therapy
  • beam radiation therapy
  • beam therapy
  • behavior therapy
  • behavioral therapy
  • behaviour therapy
  • behavioural therapy
  • beta-blocker therapy
  • bevacizumab therapy
  • biologic therapy
  • biological therapy
  • bisphosphonate therapy
  • blocker therapy
  • bolus therapy
  • boron neutron capture therapy
  • botulinum toxin therapy
  • brain radiation therapy
  • breast cancer therapy
  • breast conservation therapy
  • breast-conserving therapy
  • bridging therapy
  • brief therapy
  • bright light therapy
  • bronchodilator therapy
  • c therapy
  • cam therapy
  • canal therapy
  • cancer gene therapy
  • cancer therapy
  • capture therapy
  • cardiac resynchronization therapy
  • cardiac therapy
  • care therapy
  • cell replacement therapy
  • cell therapy
  • cellular therapy
  • chelation therapy
  • chemoradiation therapy
  • choice therapy
  • chronic therapy
  • cisplatin therapy
  • clinical therapy
  • cognitive behavior therapy
  • cognitive behavioral therapy
  • cognitive behaviour therapy
  • cognitive behavioural therapy
  • cognitive therapy
  • cognitive-behavior therapy
  • cognitive-behavioral therapy
  • cognitive-behavioural therapy
  • combination antiretroviral therapy
  • combination therapy
  • combined therapy
  • commitment therapy
  • common therapy
  • complementary therapy
    		•
  • compression therapy
  • concomitant immunosuppressive therapy
  • concomitant therapy
  • concurrent therapy
  • conditioning therapy
  • conformal radiation therapy
  • conservation therapy
  • conservative therapy
  • conserving therapy
  • consolidation therapy
  • continued therapy
  • continuous positive airway pressure therapy
  • continuous renal replacement therapy
  • control therapy
  • conventional therapy
  • corticosteroid therapy
  • couple therapy
  • cpap therapy
  • curative therapy
  • current antiviral therapy
  • current standard therapy
  • current therapy
  • cutaneous gene therapy
  • cyclophosphamide therapy
  • cyclosporin therapy
  • cyclosporine therapy
  • cytokine therapy
  • cytoreductive therapy
  • cytotoxic therapy
  • d therapy
  • day therapy
  • dc therapy
  • debridement therapy
  • defibrillator therapy
  • definitive therapy
  • depigmentation therapy
  • depletion therapy
  • deprivation therapy
  • desensitization therapy
  • destination therapy
  • destructive therapy
  • device therapy
  • dexamethasone therapy
  • diabetes therapy
  • dialysis therapy
  • diet therapy
  • dietary therapy
  • different therapy
  • differentiation therapy
  • discontinuing therapy
  • disease modifying therapy
  • disease therapy
  • disease-modifying therapy
  • diuretic therapy
  • dopa therapy
  • dopamine replacement therapy
  • dopaminergic therapy
  • dose therapy
  • doxycycline therapy
  • drug therapy
  • dual antiplatelet therapy
  • dual therapy
  • dynamic therapy
  • e therapy
  • early goal-directed therapy
  • early therapy
  • effective adjuvant therapy
  • effective cancer therapy
  • effective gene therapy
  • effective systemic therapy
  • effective therapy
  • efficacious therapy
  • electrical therapy
  • electroconvulsive therapy
  • emerging therapy
  • empiric therapy
  • empirical antibiotic therapy
  • empirical therapy
  • endocrine therapy
  • endodontic therapy
  • endoscopic therapy
  • endovascular therapy
  • enhancement therapy
  • entecavir therapy
  • enzyme prodrug therapy
  • enzyme replacement therapy
  • enzyme therapy
  • epigenetic therapy
  • eradication therapy
  • erythropoietin therapy
  • established therapy
  • estrogen replacement therapy
  • estrogen therapy
  • etanercept therapy
  • ex vivo gene therapy
  • exchange therapy
  • exercise therapy
  • expensive therapy
  • experimental therapy
  • exposure therapy
  • external beam radiation therapy
  • external radiation therapy
  • factor therapy
  • family therapy
  • fibrinolytic therapy
  • first choice therapy
  • first line therapy
  • first-line therapy
  • fluid therapy
  • focal therapy
  • foscarnet therapy
  • front-line therapy
  • frontline therapy
  • future therapy
  • ganciclovir therapy
  • gefitinib therapy
  • gemcitabine therapy
  • gene therapy
  • genetic therapy
  • gh therapy
  • glucocorticoid therapy
  • goal-directed therapy
  • group therapy
  • growth factor therapy
  • growth hormone therapy
  • h. pylori eradication therapy
  • h. pylori therapy
  • haart therapy
  • hbo therapy
  • hcv therapy
  • helicobacter pylori eradication therapy
  • helicobacter pylori therapy
  • hemodialysis therapy
  • heparin therapy
  • herbal therapy
  • high-dose therapy
  • highly active antiretroviral therapy
  • hiv therapy
  • home therapy
  • hormonal therapy
  • hormone replacement therapy
  • hormone therapy
  • hormone-replacement therapy
  • hydroxyurea therapy
  • hyperbaric oxygen therapy
  • hypertension therapy
  • ibd therapy
  • icd therapy
  • ifn therapy
  • il-2 therapy
  • imatinib mesylate therapy
  • imatinib therapy
  • immediate therapy
    		•
  • immune therapy
  • immune-modulating therapy
  • immunoglobulin therapy
  • immunomodulating therapy
  • immunomodulatory therapy
  • immunosuppressant therapy
  • immunosuppressive therapy
  • implant therapy
  • inappropriate icd therapy
  • inappropriate therapy
  • individual therapy
  • individualized therapy
  • induction therapy
  • infliximab induction therapy
  • infliximab therapy
  • infusion therapy
  • inhalation therapy
  • inhaled corticosteroid therapy
  • inhaled therapy
  • inhibitor therapy
  • initial antibiotic therapy
  • initial periodontal therapy
  • initial therapy
  • injection therapy
  • innovative therapy
  • ino therapy
  • instillation therapy
  • insulin injection therapy
  • insulin pump therapy
  • insulin therapy
  • intensive insulin therapy
  • intensive statin therapy
  • intensive therapy
  • interferon therapy
  • interpersonal therapy
  • interventional pain therapy
  • interventional therapy
  • intraoperative radiation therapy
  • intravenous immunoglobulin therapy
  • intravenous therapy
  • intravesical bcg therapy
  • intravitreal bevacizumab therapy
  • invasive therapy
  • iodine therapy
  • iron chelation therapy
  • iron therapy
  • irradiation therapy
  • isotretinoin therapy
  • ivig therapy
  • kinase inhibitor therapy
  • lamivudine combination therapy
  • lamivudine therapy
  • larval therapy
  • laser therapy
  • leflunomide therapy
  • leukemia therapy
  • levodopa therapy
  • light therapy
  • line therapy
  • linezolid therapy
  • lipid lowering therapy
  • lipid-lowering therapy
  • lipid-modifying therapy
  • lithium therapy
  • local ablative therapy
  • local therapy
  • locoregional therapy
  • long-term maintenance therapy
  • long-term therapy
  • low level laser therapy
  • low-level laser therapy
  • lowering therapy
  • maintenance therapy
  • malaria therapy
  • manipulative therapy
  • manual therapy
  • marital therapy
  • mars therapy
  • massage therapy
  • mechanical periodontal therapy
  • medical therapy
  • melatonin therapy
  • mesylate therapy
  • metformin therapy
  • methadone maintenance therapy
  • methadone therapy
  • methylprednisolone pulse therapy
  • methylprednisolone therapy
  • migraine therapy
  • milieu therapy
  • mmf therapy
  • modality therapy
  • modern therapy
  • modifying therapy
  • molecular targeted therapy
  • molecular therapy
  • monoclonal antibody therapy
  • month therapy
  • motivational enhancement therapy
  • mtx therapy
  • multidrug therapy
  • multimodal therapy
  • multimodality therapy
  • multiple drug therapy
  • multiple therapy
  • music therapy
  • narrative therapy
  • natural therapy
  • necrosis factor therapy
  • negative pressure therapy
  • negative pressure wound therapy
  • neoadjuvant hormonal therapy
  • neoadjuvant therapy
  • neuroprotective therapy
  • neutron capture therapy
  • new therapy
  • newer therapy
  • nicotine replacement therapy
  • non-pharmacological therapy
  • non-surgical periodontal therapy
  • non-surgical therapy
  • nonoperative therapy
  • nonspecific therapy
  • nonsurgical therapy
  • novel therapy
  • nsaid therapy
  • nutrition therapy
  • nutritional therapy
  • occupational therapy
  • octreotide therapy
  • oestrogen therapy
  • on-demand therapy
  • opioid therapy
  • optimal medical therapy
  • optimal therapy
  • oral anticoagulant therapy
  • oral anticoagulation therapy
  • oral bisphosphonate therapy
  • oral combination therapy
  • oral corticosteroid therapy
  • oral rehydration therapy
  • oral therapy
  • other medical therapy
  • other therapy
  • outpatient therapy
  • oxygen therapy
  • pacing therapy
  • pain therapy
  • palliative therapy
  • pd therapy
  • pde5 inhibitor therapy
  • periodontal therapy
  • pharmacologic therapy
    		•
  • pharmacological therapy
  • photodynamic therapy
  • physical therapy
  • plasma exchange therapy
  • plasma therapy
  • positive airway pressure therapy
  • possible therapy
  • postmenopausal hormone therapy
  • postoperative adjuvant therapy
  • postoperative radiation therapy
  • potential new therapy
  • potential therapy
  • ppi therapy
  • pre-emptive therapy
  • prednisolone therapy
  • prednisone therapy
  • preemptive therapy
  • preoperative radiation therapy
  • preoperative therapy
  • present therapy
  • pressure therapy
  • pressure wound therapy
  • preventive therapy
  • previous therapy
  • primary therapy
  • prior radiation therapy
  • prior therapy
  • probiotic therapy
  • problem-solving therapy
  • prodrug therapy
  • prolonged therapy
  • promising therapy
  • prophylactic therapy
  • protein therapy
  • proton pump inhibitor therapy
  • proton-pump inhibitor therapy
  • psychological therapy
  • psychosexual therapy
  • psychosocial therapy
  • pulp therapy
  • pulse therapy
  • pump inhibitor therapy
  • pump therapy
  • puva therapy
  • pylori eradication therapy
  • pylori therapy
  • quadruple therapy
  • radiation therapy
  • radioactive iodine therapy
  • radioiodine therapy
  • rational therapy
  • receptor therapy
  • reduction therapy
  • regenerative therapy
  • regular therapy
  • rehabilitation therapy
  • rehydration therapy
  • relaxation therapy
  • reliever therapy
  • remission induction therapy
  • renal replacement therapy
  • reperfusion therapy
  • replacement therapy
  • restorative therapy
  • resynchronization therapy
  • retinoid therapy
  • revascularization therapy
  • rhythm therapy
  • ribavirin combination therapy
  • ribavirin therapy
  • rituximab therapy
  • root canal therapy
  • safe therapy
  • salvage therapy
  • same therapy
  • second-line therapy
  • sequential therapy
  • shock therapy
  • shockwave therapy
  • short-term therapy
  • sirolimus therapy
  • social rhythm therapy
  • specific therapy
  • speech therapy
  • splint therapy
  • standard medical therapy
  • standard therapy
  • standard triple therapy
  • statin therapy
  • stem cell therapy
  • steroid pulse therapy
  • steroid therapy
  • stroke therapy
  • subsequent therapy
  • substitution therapy
  • successful therapy
  • suicide gene therapy
  • supportive periodontal therapy
  • supportive therapy
  • suppression therapy
  • suppressive therapy
  • surfactant therapy
  • surgical therapy
  • symptomatic therapy
  • systemic antifungal therapy
  • systemic therapy
  • tacrolimus therapy
  • tamoxifen therapy
  • target therapy
  • targeted cancer therapy
  • targeted therapy
  • targeting therapy
  • testosterone replacement therapy
  • testosterone therapy
  • thalidomide therapy
  • three-dimensional conformal radiation therapy
  • thrombolytic therapy
  • tocolytic therapy
  • topical corticosteroid therapy
  • topical photodynamic therapy
  • topical therapy
  • topiramate therapy
  • toxin therapy
  • traditional therapy
  • transfusion therapy
  • transplantation therapy
  • trastuzumab therapy
  • triple therapy
  • triptan therapy
  • tumor therapy
  • udca therapy
  • upstream therapy
  • used therapy
  • useful therapy
  • uvb therapy
  • v.a.c. therapy
  • vaccine therapy
  • various therapy
  • vegf gene therapy
  • vitamin d therapy
  • vitamin e therapy
  • vivo gene therapy
  • voice therapy
  • vpa therapy
  • warfarin therapy
  • wave therapy
  • week therapy
  • whole brain radiation therapy
  • withdrawal therapy
  • wound therapy

    • Terms modified by Therapy

  • therapy adherence
  • therapy alone
  • therapy application
  • therapy approach
  • therapy available
  • therapy clinical trials
  • therapy clinician
  • therapy consisting
  • therapy course
  • therapy decision
  • therapy department
  • therapy device
  • therapy discontinuation
  • therapy duration
  • therapy education
  • therapy episode
    		•
  • therapy era
  • therapy evaluation
  • therapy experience
  • therapy failure
  • therapy for children
  • therapy goal
  • therapy group
  • therapy groups
  • therapy initiation
  • therapy intervention
  • therapy lead
  • therapy modality
  • therapy monitoring
  • therapy oncology group
  • therapy only
  • therapy option
    		•
  • therapy outcome
  • therapy patient
  • therapy period
  • therapy phase
  • therapy practice
  • therapy process
  • therapy products
  • therapy profession
  • therapy program
  • therapy programme
  • therapy protocol
  • therapy regimen
  • therapy research
  • therapy response
  • therapy services
  • therapy session
    		•
  • therapy strategy
  • therapy student
  • therapy study
  • therapy system
  • therapy techniques
  • therapy theory
  • therapy training
  • therapy treatment
  • therapy trials
  • therapy unit
  • therapy use
  • therapy used
  • therapy vector

    • Selected Abstracts

    Diagnosis/Therapy in Ophthalmology: Photodynamic therapy with verteporfin for vasoproliferative tumour of the retina

    ACTA OPHTHALMOLOGICA, Issue 6 2010
    Rose P. S. Chan
    First page of article [source]

    A New Section in Acta:Diagnosis/therapy in ophthalmology

    ACTA OPHTHALMOLOGICA, Issue 3 2002
    Section Editor Tero Kivel
    [source]

    MANAGEMENT OF ANTIPLATELET THERAPY FOR ENDOSCOPIC PROCEDURES: OPTIMAL CESSATION PERIOD OF ANTIPLATELET THERAPY FOR JAPANESE

    DIGESTIVE ENDOSCOPY, Issue 4 2007
    Yoshiko Tamai
    Although antiplatelet agents are widely used for the treatment and prevention of thrombotic diseases, only a few studies have reported the validity of the cessation period prior to endoscopic procedures. In 2002, the American Society for Gastrointestinal Endoscopy (ASGE) published a reference on the management of anticoagulation and antiplatelet therapy for endoscopic procedures, but it should be confirmed as appropriate for use in Asian patients. To evaluate the optimal cessation period of antiplatelet agents prior to endoscopic procedures for Japanese, we have studied: (i) the current clinically adopted cessation period of antiplatelet agents prior to invasive endoscopic procedures in Japan; (ii) the relationship between the cessation period of antiplatelet agents and complications around the invasive endoscopic procedures; (iii) colonic mucosal bleeding time after aspirin ingestion; and (iv) the time course of primary hemostasis after cessation of antiplatelet agents. We conclude that 3 days cessation period for aspirin, 5 days cessation for ticlopidine and 7 days cessation for aspirin + ticlopidine administration should be sufficient for Japanese. [source]

    LARGE HYPERPLASTIC POLYP DEVELOPING AFTER ENDOSCOPIC MUCOSAL RESECTION OF GASTRIC ADENOMA IN A PATIENT RECEIVING IMMUNOSUPPRESSIVE THERAPY

    DIGESTIVE ENDOSCOPY, Issue 2 2006
    Geum-Youn Gwak
    A 59-year-old man underwent endoscopic mucosal resection (EMR) for gastric adenoma. He had suffered from end-stage renal disease for several years and had received renal transplantation some 5 months before EMR. Subsequently, he took immunosuppressive agents. Follow-up gastrofiberscopy 6 months after EMR showed a sessile polyp at the resection site twice as large as the original adenoma; biopsy specimens revealed a hyperplastic nature. At the time of writing, this hyperplastic polyp has neither increased in size nor developed adenomatous or carcinomatous changes by histological examinations over the past 5 years. Therefore, this is a case of hyperplastic polyp occurring at the gastric adenoma resection site, and suggests the possible effect of immunosuppressive therapy on the post-EMR healing process and hyperplastic polyp development. [source]

    USEFUL ENDOSCOPIC ULTRASONOGRAPHY TO ASSESS THE EFFICACY OF NEOADJUVANT THERAPY FOR ADVANCED ESOPHAGEAL CARCINOMA: BASED ON THE RESPONSE EVALUATION CRITERIA IN SOLID TUMORS

    DIGESTIVE ENDOSCOPY, Issue 1 2005
    Masaho Ota
    Objective:, The aim of the present study was to assess the usefulness of endoscopic ultrasonography (EUS) for evaluating the efficacy of neoadjuvant therapy for advanced esophageal carcinoma based on the Response Evaluation Criteria in Solid Tumors (RECIST). Patients and Methods:, Sixty-two patients with advanced esophageal carcinoma underwent surgical resection after neoadjuvant therapy. The maximal tumor thickness was measured by EUS before and after neoadjuvant therapy, and the percent reduction was compared with the pathological response. Based on the RECIST, PD-SD (progressive disease-stable disease) was defined as < 30% reduction of tumor thickness on EUS, PR (partial response) as , 30% reduction of tumor thickness, and CR (complete response) as no detectable tumor (100%). Results:, The percent reduction of the thickness of Grade 0,1, Grade 2 and Grade 3 tumor was 11.5 ± 21.0%, 48.2 ± 17.0% and 74.9 ± 21.1%, respectively. There were significant differences in the extent of reduction among the three groups. Based on the RECIST, 80% of Grade 0,1 cases, 91% of Grade 2 cases and 22% of Grade 3 cases were PD-SD, PR, and CR according to EUS, respectively. EUS correctly identified 80% of non-responders and 94% of responders. Conclusions:, The percentage reduction of tumor thickness on EUS closely reflected the pathological evaluation. EUS evaluation based on the RECIST seems to be useful for monitoring neoadjuvant therapy in patients with esophageal carcinoma. [source]

    5 DIAGNOSTIC PITFALLS IN THE ECHOCARDIOGRAPHIC EVALUATION OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY (HOCM) REFERRED FOR CATHETER INTERVENTIONAL THERAPY

    ECHOCARDIOGRAPHY, Issue 1 2004
    G. Beer
    Introduction: Generally, the diagnosis of typical HOCM with subaortic obstruction and a dynamic pressure gradient across the left ventricular outflow tract is made by noninvasive diagnostic procedures with great certainty by employing transthoracic (TTE) and/or transoesophageal (TEE) echocardiography. However, in patients with asymmetric septal hypertrophy pitfalls in echocardiographic examination may arise from several additional diseases as described in casuistic reports. To date systematic investigations in patients referred for catheter interventional therapy of HOCM are lacking. Patients and Methods: Therefore we investigated for the first time in a systematic study 200 symptomatic patients. (180 consecutive and 20 nonconsecutive patients; functional class 3 or 4 according to NYHA) with HOCM who were referred for this new catheter interventional therapy. In all patients TTE, bicycle exercise Doppler echocardiography and multiplane TEE were performed. Results: In 4 of 180 consecutive patients. (2.2%) discrete subvalvular membranous aortic stenosis (DSAS) (3 female patients and 1 male patient; age 20 to 58 years; mean septal diameter 19 mm; Sam-like motion in all 4 patients) was made. In all cases the diagnosis could be confirmed by surgical treatment. TEE evaluation was of crucial importance with demonstration of a typical subvalvular membrane that was situated a few millimeters below the aortic valve. In all cases a typical asymmetric septal hypertrophy mimicking HOCM was seen. Additionally, in 2 patients there was a conincidence of severe symptomatic valvular aortic stenosis and HOCM and in 1 patient a tunnel type of subvalvular aortic stenosis was present. Conclusion: These results show the potential pitfalls in echocardiographic diagnosis of HOCM. Especially, the frequency of DSAS in symptomatic patients referred for HOCM is unexpectedly high (2.2%). Especially in patients in whom TTE is of insufficient quality, investigation employing multiplane TEE with careful evaluation of the small poststenotic subvalvular area in HOCM is of crucial importance. This is of special significance prior to catheter interventional therapy, because in these patients surgical treatment is mandatory. [source]

    CARBOCYSTEINE THERAPY IN OLDER PEOPLE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    JOURNAL OF AMERICAN GERIATRICS SOCIETY, Issue 11 2006
    Stephen C. Mitchell DSc
    No abstract is available for this article. [source]

    COMBINATION THERAPY FOR POSTPRANDIAL AND ORTHOSTATIC HYPOTENSION IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES MELLITUS

    JOURNAL OF AMERICAN GERIATRICS SOCIETY, Issue 4 2006
    Naomune Yamamoto MD
    No abstract is available for this article. [source]

    EXERCISE-RELATED SYNCOPE INDUCED BY VASODILATOR THERAPY IN AN ELDERLY HYPERTENSIVE PATIENT

    JOURNAL OF AMERICAN GERIATRICS SOCIETY, Issue 2 2005
    Akiyoshi Ogimoto MD
    No abstract is available for this article. [source]

    IMPLANT OR ROOT CANAL THERAPY: AN ENDODONTIST'S VIEW

    JOURNAL OF ESTHETIC AND RESTORATIVE DENTISTRY, Issue 3 2005
    Martin Trope DMD
    [source]

    SEXUAL ADDICTION AND MARRIAGE AND FAMILY THERAPY: FACILITATING INDIVIDUAL AND RELATIONSHIP HEALING THROUGH COUPLE THERAPY

    JOURNAL OF MARITAL AND FAMILY THERAPY, Issue 3 2006
    Mark H. Bird
    In recent decades there has been an increase in literature regarding sexual addiction as well as a growing number of clients presenting in therapy with problems related to their sexual behaviors (including internet sexual addiction). This article (a) presents a synthesis of the research on the impact of sexual addiction on the addict, the partner, and the couple; (b) outlines the process of healing for each based on the research synthesis; and (c) discusses the role of marriage and family therapy in facilitating both individual and relationship healing from sexual addiction. Implications for future research in sexual addiction, generally, and in marriage and family therapy, specifically, are presented. [source]

    INTEGRATING EMOTION-FOCUSED THERAPY WITH THE SATIR MODEL

    JOURNAL OF MARITAL AND FAMILY THERAPY, Issue 2 2006
    Lorrie Brubacher
    The experiential humanistic family systems approach of Virginia Satir lacks a theoretical structure and is thus vulnerable to losing its experiential nature and being reduced to a mere collection of creative techniques. A way to effectively keep Satir's transformative presence alive is to integrate her approach with a model that is solidly grounded in explicit theory, relationship principles, and therapeutic skills and processes. The model proposed as appropriate to this effect is Emotion-Focused Therapy (EFT). Satir's approach, when integrated with EFT, becomes a model for creating change in individual and family systems that is indeed greater than the sum of its parts. [source]

    IN-HOME FAMILY THERAPY: INDICATORS OF SUCCESS

    JOURNAL OF MARITAL AND FAMILY THERAPY, Issue 4 2005
    Jeremy B. Yorgason
    In this study, we explore how specific individual, family, and family-within-community characteristics, as well as aspects of in-home family therapy, relate to responses to treatment. The Child and Adolescent Functional Assessment Scale scores and Global Assessment of Functioning scores were used as outcome measures. Results revealed significant differences between pre- and post-scores for clients receiving in-home family therapy services, providing an initial indicator of treatment success. In addition, primary family caregiver social support, role performance in school/work, and self-harmful behavior were indicative of successful outcomes. Clients with higher problem levels had the greatest rates of change, and clients receiving more hours of services fared better in therapy. [source]

    IMPACT OF MARITAL AND PSYCHOLOGICAL DISTRESS ON THERAPEUTIC ALLIANCE IN COUPLES UNDERGOING COUPLE THERAPY

    JOURNAL OF MARITAL AND FAMILY THERAPY, Issue 2 2005
    Salima Mamodhoussen
    In this study, we describe the psychometric properties of the Couple Therapy Alliance Scale, revised (CTAS,r) and investigates the impact of marital and psychiatric distress on alliance. Seventy-nine couples in therapy completed a French version of the Dyadic Adjustment Scale and of the Psychiatric Symptoms Index at session one, and a French version of the CTAS,r at session three. Results indicate that the French version of the CTAS,r has adequate psychometric properties, although the subscales of the instrument are highly intercorrelated. Furthermore, marital adjustment predicts alliance scores, whereas psychiatric symptoms do not. Finally, male marital adjustment and female psychiatric symptoms are lower in couples where spouses have divergent perceptions of the alliance. Future research directions are discussed. [source]

    INITIAL LEVELS OF DIFFERENTIATION AND REDUCTION IN PSYCHOLOGICAL SYMPTOMS FOR CLIENTS IN MARRIAGE AND FAMILY THERAPY

    JOURNAL OF MARITAL AND FAMILY THERAPY, Issue 1 2005
    Suzanne Bartle-Haring
    Using Bowen Family Systems Theory as a theoretical underpinning, in this study, we investigated the hypothesis that clients with higher levels of differentiation would improve more quickly in therapy than clients with lower levels of differentiation. Hierarchical Linear Modeling was used to analyze the data over nine sessions of therapy in a sample from an on-campus training clinic. The results suggest that there was variation in the initial levels of psychological symptoms and that differentiation was a significant predictor of this variance. The results also suggest that although psychological symptoms decreased over the nine sessions of therapy, there was very little variance in this change. These results are discussed in relation to Bowen Theory. The difficulties of doing this type of research and the lessons learned from this project are also discussed. [source]

    BEYOND COMMON FACTORS: MULTILEVEL-PROCESS MODELS OF THERAPEUTIC CHANGE IN MARRIAGE AND FAMILY THERAPY

    JOURNAL OF MARITAL AND FAMILY THERAPY, Issue 2 2004
    Thomas L. Sexton
    A number of scholars have proposed the common factors perspective as the future direction of marriage and family therapy (MFT). Although intuitively appealing, the case for the common factors perspective is not as clear-cut as proponents portray. In its current form, the common factors perspective overlooks the multilevel nature of practice, the diversity of clients and settings, and the complexity of therapeutic change. In contrast, comprehensive process-based change models are analternative to the limitations of common factors. In this article, we consider the limitations of the common factors perspective and propose the necessary and sufficient components and processes that might comprise comprehensive, multilevel, process-based therapeutic change models in MFT. [source]

    CHRONIC ILLNESS IN COUPLES: A CASE FOR EMOTIONALLY FOCUSED THERAPY

    JOURNAL OF MARITAL AND FAMILY THERAPY, Issue 3 2003
    John Kowal
    The onset of chronic illness is one of the most pervasive health problems facing North Americans today. Only recently have researchers and clinicans seriously examined chronic physical conditions in the context of close relationships. This article briefly reviews the literature on chronic illness in adult couples. Initially, the focus is on the reciprocal link between close relationships and chronic physical conditions. A number of clinical approaches for working with chronic illness in couples are outlined, a particular case is made for the utility of emotionally focused therapy, and a case study is presented. [source]

    CONTEXTUAL ASSESSMENT OF COUPLES THERAPY: THE CLINICAL DISCOURSE Q-SETS

    JOURNAL OF MARITAL AND FAMILY THERAPY, Issue 4 2002
    Steven M. Kogan
    This article describes a method for creating highly contextual assessments of couples therapy interaction using concepts from Systemic Functional Linguistics (SFL). According to SFL, talk in interaction serves three primary functions: to mediate social relations, to negotiate representations of reality, and to organize and structure the event as coherent. These concepts are operationalized using observational q-methodology. The Clinical Discourse Q-Sets (CDQS) include three separate q-sets for use by trained observers in rating 12-min segments of couples therapy conversation. Each q-set captures one aspect of the communication process as defined by Systemic Functional theory. Good-to-high reliabilities for the q-set profiles over various (n=16) couples therapy episodes were found. Preliminary evidence for the conceptual structure and clinical validity of the system was found. [source]

    THE THERAPEUTIC ALLIANCE IN HOME-BASED FAMILY THERAPY: IS IT PREDICTIVE OF OUTCOME?

    JOURNAL OF MARITAL AND FAMILY THERAPY, Issue 1 2002
    Lee N. Johnson
    This study examined the association between the therapeutic alliance in family therapy and changes in symptom distress, interpersonal relationships, and family coping. The participants (N = 81) were members of low socioeconomic status families referred to a university clinic for in-home family therapy. Participants completed the Outcome Questionnaire, Family Crisis Oriented Personal Evaluation, and the Family Therapy Alliance questionnaires. Regression analyses revealed that the therapeutic alliance explained 19% of the variance in symptom distress changes for mother, 55% for fathers, and 39% for adolescents. The implications of these findings for practicing and researching family therapy are presented. [source]

    EXPANDING BOWEN'S LEGACY TO FAMILY THERAPY: A RESPONSE TO HORNE AND HICKS

    JOURNAL OF MARITAL AND FAMILY THERAPY, Issue 1 2002
    Carmen Knudson-Martin
    In response to Horne and Hicks's critique of my 1994 revision of Bowen Theory, I present an updated rationale for my work. I argue that the primary difference in my construction of emotional differentiation rests in the way "self" is constructed. I suggest that many women, persons from less individualistic cultures, and very spiritual persons develop a "connected self" that is significantly different than Bowen's image of separate selves engaged with each other. I hold that Bowen Theory privileges individuality and ignores many of the positive aspects of togetherness. I put forth an inclusive model for differentiation that equally prioritizes each. [source]

    COUPLES THERAPY FOR WOMEN SURVIVORS OF CHILD SEXUAL ABUSE WHO ARE IN ADDICTIONS RECOVERY: A COMPARATIVE CASE STUDY OF TREATMENT PROCESS AND OUTCOME

    JOURNAL OF MARITAL AND FAMILY THERAPY, Issue 1 2001
    Barry Trute
    Treatment for women who are survivors of child sexual abuse and who have a history of substance abuse has largely involved gender-specific interventions. This study examines the use of conjoint couple therapy with a cohort of women who were survivors of child sexual abuse and who are in addiction recovery and with their partners. A comparative case study analysis incorporated standardized clinical measures with client and therapist interviews. Brief conjoint therapy was found to assist couples in the specific relationship skill areas of communication and mutual problem solving. Further, substantive gains were found in the realm of affective relations. The women reported an increase in support from their male partners, and the men reported a decrease in negative emotional atmosphere in the relationship. [source]

    ENHANCING FAMILY THERAPY: THE ADDITION OF A COMMUNITY RESOURCE SPECIALIST

    JOURNAL OF MARITAL AND FAMILY THERAPY, Issue 1 2001
    H. Charles Fishman
    First page of article [source]

    GAY AND LESBIAN COUPLES IN THERAPY: PERSPECTIVES FOR THE CONTEMPORARY FAMILY THERAPIST

    JOURNAL OF MARITAL AND FAMILY THERAPY, Issue 4 2000
    Claudia Bepko
    This paper outlines the major concerns of gay and lesbian couples who seek therapy. Presenting problems are classified as either internal to the relationship or as external (contextual) ones that reflect the influence of oppressive cultural and gender biases. Throughout the article, distinctive therapy methods are described that address the unique concerns of lesbian and gay couples, with special sensitivity to heterosexist and homophobic bias. [source]

    THERAPY WITH LESBIAN AND GAY PARENTS AND THEIR CHILDREN

    JOURNAL OF MARITAL AND FAMILY THERAPY, Issue 4 2000
    Jane Ariel
    This article explores some of the social and clinical issues facing the many different kinds of gay and lesbian families that are becoming increasingly visible in the United States. Research findings are discussed that dispel popularly held myths and sterotypes concerning these families, gays and lesbians as parents, and their children. Clinical vignettes are presented to illustrate issues often encountered in the consulting room, some unique to gay and lesbian families and some common to all families. [source]

    THE INFLUENCE OF MARITAL AND FAMILY THERAPY ON HEALTH CARE UTILIZATION IN A HEALTH-MAINTENANCE ORGANIZATION

    JOURNAL OF MARITAL AND FAMILY THERAPY, Issue 3 2000
    David D. Law
    Research has shown that people reduce their use of health care after individual psychotherapy. However, little research has been done to learn if marital and family therapy has a similar effect. Subjects (n = 292) from a health-maintenance organization were randomly selected according to the type of therapy they had received. Subjects' medical records were examined for 6 months before, during, and after therapy. Those who received marital and family therapy significantly reduced their use of health care services by 21.5%. These results show an "offset effect" for marriage and family therapy. [source]

    THE POWER EQUITY GUIDE: ATTENDING TO GENDER IN FAMILY THERAPY

    JOURNAL OF MARITAL AND FAMILY THERAPY, Issue 2 2000
    Shelley A. Haddock
    In the past two decades, feminist scholars have challenged the field of family therapy to incorporate the organizing principle of gender in its theory, practice, and training. In this paper, we introduce a training, research, and therapeutic tool that provides guidance for addressing or observing gender and power differentials in the practic of family therapy. As a training tool, the Power Equity Guide helps trainees to translate their theoretical understanding of feminist principles into specific behaviors in therapy. Researchers and supervisors can use the Power Equity Guide to evaluate the practice of gender-informed family therapy. We also provide specific suggestions for its use by trainers, supervisors, therapists, and researchers. [source]

    GUIDELINES FOR WEANING OF BRONCHODILATOR THERAPY

    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, Issue 12 2005
    LG Roddick
    No abstract is available for this article. [source]

    EARLY INITIATION OF PHOSPHATE LOWERING DIETARY THERAPY IN NON-DIALYSIS CHRONIC KIDNEY DISEASE: A CRITICAL REVIEW

    JOURNAL OF RENAL CARE, Issue 2009
    M.K. Sigrist
    SUMMARY Dietary management of hyperphosphatemia and hyperparathyroidism have long been important elements in the clinical management of CKD stage 4 and 5 for the prevention of mineral bone disease. The rationale for phosphate lowering has been further justified, given the accumulating data to support the association of phosphate with vascular damage, in this population who are at high risk of cardiovascular (CV) death. Phosphate is a novel CV risk factor in both CKD and in the general population, and a growing body of literature suggests that high normal serum phosphate may be a risk factor for progression of CKD. Few studies have examined hard outcomes after phosphate lowering. Nonetheless, given the balance of data both in cell, animal and human studies, the use of phosphate lowering strategies at earlier stages of CKD, perhaps even prior to serum phosphate level rising, may well be justified. This review will discuss the complications associated with higher serum phosphate, the potential benefits of early phosphate intervention, practical considerations of low phosphate diets and novel strategies for evaluating these strategies in clinical practice. [source]

    PAINFUL NEUROPATHY, MONOCLONAL GAMMOPATHY AND AMYLOID DEPOSITS: RESPONSE TO THERAPY IN 3 CASES

    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, Issue 1 2002
    Article first published online: 11 MAR 200
    Siciliano G.1, D'Avino C.1, Panichi V.2, Azzarà A.3, Del Corona A.1, Pollina L.3, Murri L.1 1Department of Neuroscience, 2Department of Internal Medicine and 3Department of Oncology,University of Pisa-Italy Amyloidosis is a systemic disease with a wide organic involvement. Amyloidotic polyneuropathies may be genetic in their origin or present in association with a number of chronic inflammatory dysimmune disorders. We report on three patients affected by predominantly sensitive polyneuropathy, monoclonal gammopathy and amyloidosis. Patient 1. Woman, 72 years old, with a one year history of painful paraesthesias, ataxic gait and demyelinating predominantly sensitive polyneuropathy at 4 limbs also with involvement of sympathetic fibres. Blood protein electrophoresis showed a monoclonal gammopahty (IgG-k) with normal bone marrow biopsy and positivity for amyloid at fat biopsy. The patient has been treated with melphalan 0.2 mg/Kg/day+prednisone 100 mg/day for 7 days each month for 6 months with good efficacy and only a transient reduction in platelet and white blood cells count. Patient 2. Man, 60 years old, new diagnosis of diabetes with a 9 month history of painful paraesthesias and hyposthenia, a demyelinating sensory-motor polyneuropathy at 4 limbs. The patient presented an IgG-, monoclonal gammopathy with normal bone marrow biopsy, fat biopsy but not sural nerve biopsy positive for amyloid. The patient underwent melphalan+prednisone therapy, with insulinic control of glycemia. He presented a clear-cut improvement in sensitive-motor symptomatology. Patient 3. Man, 72 years old, with a 15 year history of ulcerous rectocolites. Since 1998 started complaining of paraesthesias and disaesthesias at four limbs associated with gait disturbances. The patient presented an IgG-, monoclonal gammopathy with normal bone marrow aspiration and elevated serum Interleukin-6 levels, fat biopsy positive for amyloid, and high anti-MAG antibodies titer (1:100000). Because of RCU, melphalan therapy was excluded and the patient is at the moment under fludarabine (25 mg/m2/day) ev for 5 days each 6 weeks for 6 bouts. [source]

    POSTIRRADIATION LUMBOSACRAL RADICULOPLEXOPATHY: IMPROVEMENT AFTER IMMUNE THERAPY

    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, Issue 1 2000
    A. Bersano
    A delayed progressive impairment of peripheral nervous system including brachial and lumbosacral radiculoplexopathy is a well-known complication of local radiotherapy. No treatment for this infrequent complication is currently available. Recently, improvement after treatment with high dose immunoglobulin (IVIg) has been reported in some patients, suggesting either an immune-mediated inflammatory nerve damage induced by irradiation or a dysimmune neuropathy (CIDP-like) misdiagnosed as a postirradiation disease. We report on two patients who developed motor lumbosacral radiculoplexopathy several years after local radiotherapy. The first patient (ZA) is a 49 y.o. man developing a progressive proximal>distal weakness and hypotrophy of lower limbs, 20 years after radiotherapy of lumbosacral region for seminoma. Electrophysiological studies showed markedly reduced motor conduction velocities (CV) and prolonged F-wave latencies in lower limb nerves. The second patient (BF), is a 52 y.o. woman who developed progressive left brachial plexopathy and distal>proximal weakness and hypotrophy of lower limbs 12 years after a first course of toracoascellar and lumbar irradiation for Hodgkin lymphoma followed by a second course of cervicoclavicular irradiation for tumor recurrence 7 years later. Electrophysiological studies showed markedly reduced CMAP amplitudes and proportionally reduced CV in motor nerves. No sensory impairment was detected in both patients. CSF protein was elevated in both patients while cells were normal. On the assumption of a possible dysimmune origin of the disease, patient ZA underwent high dose intravenous steroid treatment, while patient BF, who had previously deteriorated after steroids, was treated with IVIg. After treatment, patient ZA became able to walk with less waddling, to rise from the floor and climb stairs without support, and to run. Improvement was less consistent in patient BF, whose right leg strength improved even if she still needed bilateral support to walk. The improvement observed in both patients supports the hypothesis that, at least in some patients, an immune-mediated mechanism may underlie postirradiation radiculoplexopathy. [source]